Back
to sessions
Sep 28
Poster Q & A
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
session DESCRIPTION
ASTRO's posters feature the latest scientific case studies, practice innovations and research from experts in the field of radiation oncology, including Clinical Trials in Progress.
Poster presentations will be accessible to both live and virtual meeting attendees starting at 5:00 p.m. Eastern time, on Friday, September 26, 2025. Posters can be viewed through the Annual Meeting portal and in the Virtual Poster Library.
During scheduled times, attendees will have the opportunity to ask poster presenters questions about their research. Posters will be organized by track.
Presentations
-
04:45pm - 06:00pm PT
2-Hydroxyisobutyrylation of ALDH1A3 Promotes Stemness Maintenance and Radiotherapy Resistance in NSCLC via Activation of the STAT3 Signaling Pathway
Speaker: Zhiying Zhou, - Chongqing University, Chongqing -
04:45pm - 06:00pm PT
A Novel Imaging Biomarker for Radiation Induced Cardiotoxicity
Speaker: Arezoo Modiri, PhD - University of Maryland School of Medicine, Baltimore, Baltimore -
04:45pm - 06:00pm PT
A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Survival Analysis
Speaker: Yupei Yuan, MD, MS - Cancer Hospital Chinese Academy of Medical Sciences, Beijing -
04:45pm - 06:00pm PT
A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
Speaker: Wilson Mai, MD, PhD - Stanford University Cancer Center, Stanford -
04:45pm - 06:00pm PT
A Prospective, Phase II, Single-Arm Trial Evaluating Efficacy and Safety of the Regimen of Induction Cadonilimab plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Cadonilimab Therapy for Unresectable Stage III NSCLC
Speaker: Li CHU, - FUDAN UNIVERSITY SHANGHAI CANCER CENTER, SHANGHAI -
04:45pm - 06:00pm PT
A Prospective Study on the Predictive Value of the Modified Glasgow Prognostic Score in Non-Small Cell Lung Cancer Treated with Radiation Therapy
Speaker: Zhe Chen, MD, PhD - University of Yamanashi, Chuo City -
04:45pm - 06:00pm PT
A Radiomics Method Based on Data Augmentation for Preoperative Prediction of Immature and Mature Teratoma
Speaker: Jing Yang, - Department of Radiation Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China., Hangzhou -
04:45pm - 06:00pm PT
A Temporal Perspective: Charting and Predicting Treatment Response in Breast Cancer-Related Lymphedema
Speaker: Enoch Yu, BS - Queen's University, Kingston -
04:45pm - 06:00pm PT
Advancing Adaptive Radiotherapy with High-Fidelity CBCT-Based In-Situ Dose Calculation
Speaker: Scott Hollingsworth, BS - Washington University in St. Louis School of Medicine, St Louis -
04:45pm - 06:00pm PT
Analyzing Major Depressive Disorder Risk Factors and Survival in Elderly GI Cancer Patients Using the SEER-MHOS Database
Speaker: Trudy Wu, MD, BS - University of California Los Angeles, Los Angeles -
04:45pm - 06:00pm PT
Arrythmias in Patients Receiving Thoracic Radiation
Speaker: Holly Grace, MD - UT Southwestern Medical Center, Dallas -
04:45pm - 06:00pm PT
Assessing Construct Validity of ESAS in Minority Populations and Exploring Temporal Variations in PROs by HPV Status Using PCA
Speaker: Shelly Sharma, MD - Baylor College of Medicine Hospital, Houston -
04:45pm - 06:00pm PT
Assessing Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-Up Visits for Patients Undergoing Radiation Therapy for Breast Cancer
Speaker: Marco Santos Teles, BS - Rutgers New Jersey Medical School, Newark -
04:45pm - 06:00pm PT
Assessment of Baseline Financial Toxicity and Associated Social Determinants of Health among a Diverse Patient Population Undergoing Radiation Treatment
Speaker: Chaewon Hwang, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston -
04:45pm - 06:00pm PT
Assessment of the Appropriateness of the Selection for Radiotherapy Intensity from a Quality of Life (EORTC QLQ-C30) Perspective in Older Cancer Patients
Speaker: Shigehiko Kuribayashi, MD, PhD - Tokyo Women's Medical University, Tokyo 162-8666 -
04:45pm - 06:00pm PT
Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy
Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Associations between Heart Rate Elevation, Tachycardia and Cardiac Substructure Dose in Patients Receiving Chemoradiotherapy for Non-Small Cell Lung Cancer (NSCLC)
Speaker: Florence Keane, MD - Massachusetts General Hospital/ Harvard Medical School, Boston -
04:45pm - 06:00pm PT
Automated Radiation Response Assessment with Deep Learning and Radiomics in Pediatric Diffuse Midline Glioma
Speaker: Reza Mojahed-Yazdi, MS - Harvard Medical School, Boston -
04:45pm - 06:00pm PT
Balancing Quality of Life Considerations and Efficacy of Stereotactic Body Radiotherapy in Patients with Interstitial Lung Disease
Speaker: Simran Polce, MD - Moffitt Cancer Center, Tampa -
04:45pm - 06:00pm PT
Bayesian Model-Based Internal Target Volume Accounting for Interfractional Hilum Shifts during Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Speaker: Kazuhito Ueki, MD, PhD - National Hospital Organization Kyoto Medical Center, Kyoto -
04:45pm - 06:00pm PT
Begin with the End in Mind: Assessing Symptom Index for Patients with Prostate Cancer to Select the Right Bladder Protocol for Radiotherapy
Speaker: Omar Iskanderani, MD - King Abdulaziz University, Jeddah -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Biomarker Analysis of Iruplinalkib Combined with Chemoradiotherapy in ALK+ Unresectable Stage ? Non-Small Cell Lung Cancer
Speaker: Linlin Wang, MD, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Bridging the Gap: Evaluating Patient Perceptions and Expectations of Radiation Therapy (PERT) Pre- and Post-Consultation
Speaker: Ari Kassardjian, MD - City of Hope Comprehensive Cancer Center, Duarte -
04:45pm - 06:00pm PT
Can Simulation CTs be Used to Identify and Intervene on Incidental Coronary Artery Disease in Patients with Breast Cancer?
Speaker: Kevin Chen, MD, MSCI - Washington University in St. Louis, St. Louis -
04:45pm - 06:00pm PT
Cardiac Risk, Outcomes, and Management among Older Adults with Stage I-II NSCLC Undergoing Stereotactic Body Radiation Therapy
Speaker: Sanjana Shah, BS - Harvard Medical School, Boston -
04:45pm - 06:00pm PT
Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics
Speaker: James Shen, MD, PhD - Yale Therapeutic Radiology, New Haven -
04:45pm - 06:00pm PT
Cardioprotective Medications and the Incidence of Cardiovascular Events in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
Speaker: Vishwa Pakeerathan, MBBS - Princess Alexandra Hospital, Woolloongabba -
04:45pm - 06:00pm PT
Cardiovascular Outcomes Following Total Body Irradiation (TBI) in Children:A Systematic Review and Metanalysis
Speaker: Aahan Arif, MBBS - St. Jude Children's Research Hospital, Memphis -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Chemoradiotherapy Integrated Tumor Cell Microparticles Elicit Ferroptosis and Immune Remodeling in Malignant Pleural Effusion
Speaker: Minqi Zhou, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan -
04:45pm - 06:00pm PT
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Pathologic Stage III-N2 Non-Small Cell Lung Cancer Patients Receiving Postoperative Radiotherapy Following Lobectomy: An Analysis of a Prospective Cohort
Speaker: Nengyang Wang, MD - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai -
04:45pm - 06:00pm PT
Clinical and Pathological Characteristics of Exceptionally Young Patients with Multiple Primary Lung Cancers (ExY-MPLC) - Updated Data
Speaker: Xiaomin Zhang, - Department of Radiation Oncology, Peking University Shenzhen Hospital,Shen Zhen,China, Guangdong -
04:45pm - 06:00pm PT
Clinical Efficacy and Adverse Effects of Radiotherapy in Pediatric Medulloblastoma with Residual or Disseminated Disease - A Single Center Experience
Speaker: Xuejiao Shi, MD, PhD - Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, shanghai -
04:45pm - 06:00pm PT
Clinical Factors Associated with Urinary Morbidity in Men Undergoing Combination Prostate Radiation Therapy
Speaker: Benjamin Lee, MD - Urology of Greater Atlanta, Stockbridge -
04:45pm - 06:00pm PT
Clinical Features and Treatment Outcomes of Pediatric Abdominal and Pelvic Rhabdomyosarcoma
Speaker: Yuqing Wang, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Clinical Outcomes of Neoadjuvant Chemoimmunotherapy vs. Neoadjuvant Chemoradiotherapy in the Treatment of Operable Non-Small Cell Lung Cancer
Speaker: Tal Sherman, MS, BS - Drexel University College of Medicine, Philadelphia -
04:45pm - 06:00pm PT
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Centrally and Ultracentrally Located Early-Stage Lung Cancer
Speaker: Nikunj Patil, MD, MBBS - Kasturba Medical College, Manipal -
04:45pm - 06:00pm PT
Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects in Previously Treated Patients with Stage IV Thymic Tumors: A Prospective Study
Speaker: Min Fan, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
04:45pm - 06:00pm PT
Comparative Study of HEDOS and EDIC for Predicting 2-Year Survival in Locally Advanced NSCLC Patients Undergoing Radiotherapy
Speaker: Alessandro Cicchetti, MD, PhD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan -
04:45pm - 06:00pm PT
Comparison of Changes in Pulmonary Function after SBRT vs. Surgery for Early-Stage Non-Small Cell Lung Cancer: A Prospective Real-World Observational Study
Speaker: Yue Wang, Grad Student - Tianjin Medical University Cancer Institute and Hospital, Tianjin -
04:45pm - 06:00pm PT
Comparison of Scanning Beam Proton Therapy vs. Photon IMRT in Patients with Locally Advanced Non-Small Cell Lung Cancer
Speaker: Model Zerfu, BS - University of Washington-Fred Hutchinson Cancer Center, Seattle -
04:45pm - 06:00pm PT
Comparison of the Efficacy of Immune Therapy Combined with Radiotherapy in Non-Gene-Sensitive Mutant NSCLC Brain Metastasis Patients: A Comparison of Whole-Brain Radiotherapy and Stereotactic Radiosurgery
Speaker: Erha Munai, - School of Medicine, Chongqing University, Chongqing, China, Chongqing -
04:45pm - 06:00pm PT
Concurrent Immunotherapy Improves Progression-Free Survival but Increases Toxicity in Unresectable Stage III NSCLC
Speaker: Dawei Chen, MD, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Contemporary Experience with Percutaneous High Dose Rate (HDR) Brachyablation for Malignant Lung Tumors
Speaker: Michelle Ann Eala, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
04:45pm - 06:00pm PT
Cranial Radiotherapy Improves Survival in Brain Metastatic NSCLC Patients Bearing EGFR and TP53 Mutations
Speaker: LU WANG, MD, PhD - Department of radiotherapy oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, chongqing -
04:45pm - 06:00pm PT
Daily vs. Every-Other-Day Stereotactic Body Radiotherapy for Treatment of Ultra-Central and Central Non-Small Cell Lung Cancer
Speaker: Taylor Skelly, PharmD - University of Pittsburgh School of Medicine, Pittsburgh -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Delphi Consensus on Managing Non-Small Cell Lung Cancer (NSCLC) in Patients with Coexisting Interstitial Lung Disease
Speaker: Alexander Louie, MD, PhD, MSc, FRCPC - Sunnybrook Health Sciences Centre, Toronto -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Development and Validation of a Dynamic Nomogram for Predicting Brain Metastasis in Stage III NSCLC Patients Undergoing Definitive Chemoradiotherapy
Speaker: Xianyan Chen, MD, PhD - West China Hospital of Sichuan University, Chengdu -
04:45pm - 06:00pm PT
Development of a Time-Weighted Technique to Improve the Accuracy of Amplitude-Based 4D-CT in Lung Cancer Radiotherapy
Speaker: Jihyeon Joo, MD, PhD - Pusan National University School of Medicine, Yangsan -
04:45pm - 06:00pm PT
Do Patients with Head and Neck Cancer Feel Anxious about Mask Use during Radiotherapy? Importance of Medical Support and Coping Strategies
Speaker: Rachida Laraichi, PhD - National Institute of Oncology, Rabat -
04:45pm - 06:00pm PT
Does Curative Radiotherapy Impact Fatigue Onset in Gynecological Cancer Patients? A 20-Year Single Institutional Experience in 501 Patients
Speaker: Paolo Bonome, MD - Responsible Research Hospital, Campobasso -
04:45pm - 06:00pm PT
Domain-Specific Quality-of-Life Outcomes in GI Malignancies: A Comparative Analysis of SBRT, PBT and IMRT
Speaker: Nikita Gupta, BS - Georgetown University School of Medicine, Washington -
04:45pm - 06:00pm PT
Dosimetric Evaluation of Radiotherapy Planning Optimization Based on Cardiac Subvolumes in Patients with Lung Cancer
Speaker: H. Fazilet Dincbas, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of a Prospective Trial
Speaker: Nikhil Mankuzhy, MD - Memorial Sloan Kettering Cancer Center, Middletown Township -
04:45pm - 06:00pm PT
Dynamic Change of Systemic Inflammatory Score in Predicting Survival of Patient with Unresectable Stage III Non-Small Cell Lung Cancer Treated by Definitive Chemoradiotherapy with or without Consolidate Immunotherapy: A Single-Arm, Retrospective Study
Speaker: Shihong Luo, MD, MS - National Cancer Center CAMS & PUMC, Beijing -
04:45pm - 06:00pm PT
Effects of Liberalizing Lung V5 on Intermediate and High-Dose Exposure: Insights from Lung and Esophageal Cases Treated with Photons
Speaker: Patrick Oh, MD - Yale School of Medicine, New Haven -
04:45pm - 06:00pm PT
Efficacy Analysis of Different Adjuvant Therapy Regimens in the Perioperative Period for Resectable Non-Small Cell Lung Cancer with Negative Driver Genes
Speaker: Jiarui Zhao, MBBS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan -
04:45pm - 06:00pm PT
Efficacy and Safety of Hypofractionated Radiotherapy Plus Sequential Chemotherapy with Immunotherapy in Patients with Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
Speaker: Yue Yu, - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing -
04:45pm - 06:00pm PT
Efficacy and Safety of Moderate-Dose SBRT for Patients with Oligometastatic Lung Cancer Ineligible for Standard SBRT
Speaker: Jongmoo Park, MD, PhD - Kyungpook National University Chilgok Hospital, Daegu -
04:45pm - 06:00pm PT
Efficacy and Safety of Oral Chemotherapy Concurrent Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer after Neoadjuvant Chemoimmunotherapy
Speaker: Lei Deng, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
04:45pm - 06:00pm PT
Efficacy and Safety of Thoracic Radiotherapy in Untreated Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Multicenter Retrospective Analysis
Speaker: Huiwen Yang, - Shandong Cancer Hospital, Jinan -
04:45pm - 06:00pm PT
Enhanced Survival in Stage IV NSCLC Patients: A Comparison of Sequential vs. Concurrent Radiotherapy Combined with Immunotherapy
Speaker: Yuqi Wang, MD, RT - Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical-Sciences, Jinan -
04:45pm - 06:00pm PT
Enhancing Adverse Event Monitoring in Prostate Cancer Care with Large Language Models
Speaker: Monique Shotande, PhD - Moffitt Cancer Center, Tampa -
04:45pm - 06:00pm PT
Esophageal Toxicity in Radical Radiotherapy Treatment of Malignant Pleural Mesothelioma
Speaker: Alberto Revelant, MD - CRO AVIANO, Aviano -
04:45pm - 06:00pm PT
Evaluating Outcomes in NSCLC Patients Receiving Amivantamab and Intracranial Radiation
Speaker: Nahid Howard, MS - Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona -
04:45pm - 06:00pm PT
Evaluating [<sup>18</sup>F]Fluorodeoxyglucose (FDG) Uptake as a Prognostic Metric in Stage IV Lung Cancer Patients Being Treated with Pharmacological Ascorbate and Chemotherapy
Speaker: Ashley Way, MD - University of Iowa Hospitals & Clinics, Iowa City -
04:45pm - 06:00pm PT
Evaluating the Efficacy of Postoperative Radiotherapy in Thymoma Patients with Myasthenia Gravis
Speaker: Rongrong Zhou, MD, DO, PhD, BSN - Xiangya Hospital, Changsha -
04:45pm - 06:00pm PT
Evaluation of Cumulative Doses to Organs at Risk during Lung Reirradiation
Speaker: Navid Fallahi, MD - VCU Medical Center North Hospital - Massey Cancer Center, Richmond -
04:45pm - 06:00pm PT
Evaluation of Factors Affecting Radiological Changes and Treatment Response Following LUNG Stereotactic Ablative Radiotherapy
Speaker: H. Fazilet Dincbas, MD - Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul -
04:45pm - 06:00pm PT
Evaluation of Physical Activity, Biological Rhythm, and Eating Behavior in Cancer Patients Receiving Radiation Therapy
Speaker: Hatice Kubra Gunduz, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul -
04:45pm - 06:00pm PT
Examining the Relationship between Cumulative Radiotherapy Dose to the Nipple-Areolar Complex and Breast Sensorisexual Function
Speaker: Amarachi Okorom, BA - Icahn School of Medicine at Mount Sinai, Bronx -
04:45pm - 06:00pm PT
Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations
Speaker: Peter Wilson, MD - University of Minnesota, Minneapolis -
04:45pm - 06:00pm PT
Exploration on Perioperative Treatment Strategies of Driver Gene-Positive Resectable Non-Small Cell Lung Cancer
Speaker: Xingpeng Wang, MD - School of Clinical Medicine, Shandong Second Medical University, Jinan -
04:45pm - 06:00pm PT
Exploratory Study on the Impact of Intestinal Low-Dose Radiation on the Efficacy and Prognosis of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Speaker: Baiyang Huang, MS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China, Jinan -
04:45pm - 06:00pm PT
Factors Associated with Prostate Cancer Survivors' Engagement in the Community, Results from a Population-Based Cohort
Speaker: Shelby Watts, BS - University of Kansas Medical Center, Kansas City -
04:45pm - 06:00pm PT
FGFR3 Mediates Radioresistance in Non-Small Cell Lung Cancer through Reprogramming of Fatty Acid Metabolism
Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Fifteen-Year Trends in Single-Fraction SBRT Utilization for Stage I Non-Small Cell Lung Cancer
Speaker: Drew Moghanaki, MD, FASTRO, MPH - David Geffen School of Medicine at UCLA, Los Angeles -
04:45pm - 06:00pm PT
Financial Distress Does Not Increase after Radiation Therapy: Analysis of Change in COST Score before and after Radiation Therapy
Speaker: Samyak Badkul, BS - Kansas Health Science Center, Wichita -
04:45pm - 06:00pm PT
Financial Stress and Cost-Coping Behaviors Associated with Financial Toxicity among a Diverse Patient Population Undergoing Radiation Treatment
Speaker: Chaewon Hwang, MD - Tufts Medical Center | Beth Israel Deaconess Medical Center, Boston -
04:45pm - 06:00pm PT
Financial Toxicity in Patients with Sarcoma Undergoing Radiation Therapy
Speaker: Rachel Zhang, BA - UCI School of Medicine, Orange -
04:45pm - 06:00pm PT
Functional Outcome Evaluation of Stereotactic Radiosurgery Treatment for Essential and Parkinsonian Tremor - A Private Institution Evaluation
Speaker: Ann Pittier, MD - Tacoma/Valley Radiation Oncology, Tacoma -
04:45pm - 06:00pm PT
Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance
Speaker: Victor Lee, MD, BS - Yale New Haven Hospital, Middletown -
04:45pm - 06:00pm PT
Geriatric Assessment among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston -
04:45pm - 06:00pm PT
Harnessing Lactate-Efflux Inhibition to Sensitize Radiotherapy: A Metabolic-Immune Dual-Targeting Strategy for NSCLC
Speaker: Wenqian Yuan, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan -
04:45pm - 06:00pm PT
High PD-L1 Expression is Associated with Adaptive Replanning in Patients with Locally Advanced (LA) Non-Small Cell Lung Carcinoma (NSCLC) Treated with Chemoradiotherapy (chemoRT)
Speaker: Jennifer Zagelbaum, MD, PhD - Harvard Radiation Oncology Program, Boston -
04:45pm - 06:00pm PT
Higher Baseline Monocyte and Neutrophil Counts Are Associated with Significantly Worse Overall Survival in NSCLC Patients Treated with Curative-Intent Chemoradiation
Speaker: Mathieu Gaudreault, PhD - Peter MacCallum Cancer Centre, Melbourne -
04:45pm - 06:00pm PT
High-Risk Carotid Artery Ultrasound Findings in Head and Neck Cancer Survivors after Radiation Therapy: Results of a Prospective Study
Speaker: Ryan Hughes, MD - Wake Forest University School of Medicine, Winston Salem -
04:45pm - 06:00pm PT
Hyperfractionated Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Retrospective Study
Speaker: Wei Zhou, MD, BS - Chongqing Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Hypofractionated Radiotherapy Sequenced with Immuno-Chemotherapy for Limited-Stage Small-Cell Lung Cancer
Speaker: Kunpeng Xu, MD - National Cancer & Clinical Research Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen -
04:45pm - 06:00pm PT
Identification of Dosimetric and Clinical Predictors for Post-Treatment Pulmonary Hospitalizations in NSCLC
Speaker: Josiah Nieto, MD - University of Michigan, Ann Arbor -
04:45pm - 06:00pm PT
Identification of Radioresistance Biomarkers Using Surface-Enhanced Raman Scattering (SERS) Molecular Diagnosis and Multi-Omics in NSCLC Cells
Speaker: Nan Li, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China, Chongqing -
04:45pm - 06:00pm PT
Imaging and Clinical Outcomes following Definitive Radiation Therapy for Children with High-Grade Glioma
Speaker: Soumya Unnikrishnan, MD, MS - Winship Cancer Institute of Emory University, Atlanta -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Impact of Hepatic Radiotherapy on Survival Outcomes in Small Cell Lung Cancer Patients with Liver Metastases: A Retrospective Study
Speaker: Xiangjiao Meng, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Impact of Household Income on Symptom Burden and Quality of Life in Long-Term Head and Neck Cancer Survivors
Speaker: Reagan Andersen, BS - University of Alabama at Birmingham, Birmingham -
04:45pm - 06:00pm PT
Impact of Lung Dose on Pulmonary Function Decline after Stereotactic Body Radiation Therapy for Lung Cancer
Speaker: Hidekazu Tanaka, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube -
04:45pm - 06:00pm PT
Impact of PDL-1 Expression on Long Term Disease Outcomes in Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Chemoradiation with or without Immunotherapy
Speaker: Charvi Shah, BS - Rutgers Robert Wood Johnson Medical School, New Brunswick -
04:45pm - 06:00pm PT
Impact of Prolonged Overall Treatment Time on Prognosis in Patients with Limited-Stage Small-Cell Lung Cancer Treated with Definitive Chemoradiotherapy
Speaker: Miki Kajima, MD - Yamaguchi University Graduate School of Medicine, Ube -
04:45pm - 06:00pm PT
Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney
Speaker: David Gannon, MD - Vanderbilt University Medical Center, Nashville -
04:45pm - 06:00pm PT
Impact of Radiotherapy on Fatigue in Prostate Cancer Patients: An Analysis of 1253 Patients
Speaker: Paolo Bonome, MD - Responsible Research Hospital, Campobasso -
04:45pm - 06:00pm PT
Impact of Radiotherapy-to-Tyrosine Kinase Inhibitor Sequence and Time-Interval on Pneumonitis and Treatment Discontinuation in EGFR/ALK-Mutated Non-Small Cell Lung Cancer
Speaker: Andrea Brown, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore -
04:45pm - 06:00pm PT
Impact of Smoking Status on Survival and Radiation-Induced Toxicity in Lung Cancer Patients Receiving Radiotherapy: A Retrospective Cohort Study
Speaker: Daniel Przybysz, MD - RadioSerra Radiation Therapy, Rio de Janeiro -
04:45pm - 06:00pm PT
Impact of Socioeconomic Disadvantage on Quality of Life Changes at End of Radiotherapy
Speaker: Koki Takabatake, MPH - Boston University School of Medicine, Arlington -
04:45pm - 06:00pm PT
Impact of Systematic Invasive Mediastinal Staging on Recurrence Rates Following SBRT for Early-Stage NSCLC
Speaker: Rachel Fisher, MS - University of Arizona College of Medicine - Phoenix, Phoenix -
04:45pm - 06:00pm PT
Individual Participant Data Meta-Analysis (IPDMA) and Systematic Review of Radical Radiotherapy in Oligometastatic Non Small Cell Lung Carcinoma (NSCLC)
Speaker: Ajay Kumar Kondeti, MD - All India Institute of Medical Sciences, Bibinagar, Hyderabad, Hyderabad -
04:45pm - 06:00pm PT
Induction Chemotherapy Administration Increases the Risk of Radiation Pneumonitis in Unresectable Stage III NSCLC Patients Undergoing Concurrent Chemoradiotherapy with Immunotherapy
Speaker: Pengwei Li, MS - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Induction Immunochemotherapy followed by Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer
Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai -
04:45pm - 06:00pm PT
In-Field Progression Rates Following Concurrent Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer: A Systematic Review
Speaker: Shannon Nesbit, BS - David Geffen School of Medicine at UCLA, Los Angeles -
04:45pm - 06:00pm PT
Integrating Deep and Reinforcement Learning for Detection and Segmentation of Lung Metastases from Adenoid Cystic Carcinoma (ACC) in Chest CT Scans
Speaker: Jin Sung Kim, PhD - Department of Radiation Oncology, Yonsei University College of Medicine, Seoul -
04:45pm - 06:00pm PT
Integration of Serum Metabolomics, MRI Radiomics, and Clinical Parameters for Predicting Long-Term Post-Radiotherapy Trismus in Nasopharyngeal Carcinoma: A Tri-Modal Modeling Approach
Speaker: Lei Ji, MD - The First Affiliated Hospital of Soochow University, Soochow -
04:45pm - 06:00pm PT
Intentional Protection of the Contralateral Esophagus in Thoracic Radiotherapy for Lung Cancer
Speaker: Jia-Qi Huang, - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
04:45pm - 06:00pm PT
Investigation of the 'New-PDL1' Delta Radiomic Signature for Identifying Chemo-Radiotherapy Patients Who May Benefit from Consolidation Immunotherapy
Speaker: Andrea Filippi, MD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan -
04:45pm - 06:00pm PT
Irradiation-Induced CK2/SUPT16H Axis Modulation Enhances Radiation Resistance in Lung Cancer via DNA Damage Response and Chromatin Remodeling
Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
KEAP1/NRF2 Mutation Phenotype Predicts Local Control in Early-Stage Lung Cancer Patients Treated with Stereotactic Ablative Radiotherapy
Speaker: Noah Kastelowitz, MD, PhD - Stanford University School of Medicine, Stanford -
04:45pm - 06:00pm PT
Knockdown of AKR1C1 Enhances NEDD4-Mediated Ubiquitination of GPX4 to Promote Ferroptosis and Radiosensitization in Non-Small Cell Lung Cancer
Speaker: Weiwei Yan, - Shandong Cancer Hospital Affiliated to Shandong University, Jinan -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
LncRNA SNHG17/IGF2BP1/AURKA Axis Promotes Radiation Resistance in Non Small-Cell Lung Cancer by Regulating Autophagy
Speaker: Fengti Chen, - Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning -
04:45pm - 06:00pm PT
Long-Term Survival and Undetectable Circulating Tumor DNA Following Comprehensive Involved Site Radiotherapy for Oligometastases
Speaker: Megha Schmalzle, BS - New York Institute of Technology College of Osteopathic Medicine, Old Westbury -
04:45pm - 06:00pm PT
Low-Dose Radiotherapy Enhances the Antitumor Immunity of ISABR in Non-Small Cell Lung Cancer
Speaker: Ziye Li, MD - First Affiliated Hospital of University of Science and Technology of China, Hefei -
04:45pm - 06:00pm PT
Lung V5 and Post-Radiation Lymphopenia as Predictors of Symptomatic Radiation Pneumonitis in Real-World Lung Cancer Patients in China: A Retrospective Analysis
Speaker: Qianqian Lei, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Magnetic Resonance can be Used in Guiding Hypo-Fractionated Radiotherapy for Non-Small Cell Lung Cancer
Speaker: Ligang Xing, MD, RT - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China, Jinan -
04:45pm - 06:00pm PT
MGLL-Driven Ferroptosis via ATG9A-Mediated Lipid Mobilization Enhances Radiosensitivity in NSCLC
Speaker: Yujiao Ma, MS - Shandong university, Jinan -
04:45pm - 06:00pm PT
Molecular Markers in Lung Cancer as a Predictor of Response to SBRT
Speaker: Rakhi Kaila, MD - Detroit Medical Center, Detroit -
04:45pm - 06:00pm PT
Monocyte-Macrophage Modulation in Radiation-Immunotherapy-Induced Pneumonitis in NSCLC
Speaker: Qian Zhao, MD, PhD - Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
MR vs. CT-Based Cardiac Delineation in Pediatric Patients with Hodgkin Lymphoma
Speaker: Sidharth Ramesh, MD - Hospital of the University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
MTA3-Driven Glutamine Synthetase Upregulation as a Mechanism for Radiosensitivity Regulation in Non-Small Cell Lung Cancer
Speaker: Liang Du, PhD - Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Multidisciplinary Team (MDT) Perceptions toward the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A U.S. Physician Survey
Speaker: Rebeca Mora, MD - AstraZeneca, gaithersburg -
04:45pm - 06:00pm PT
Neuroanatomical Structural Changes in Irradiated Survivors of Craniopharyngioma: A Secondary Analysis of RT3CR
Speaker: Aahan Arif, MBBS - St. Jude Children's Research Hospital, Memphis -
04:45pm - 06:00pm PT
Nutrition-Related Hematological and Body Composition Biomarkers in Stage III Unresectable NSCLC Treated with Immunochemoradiotherapy: A Retrospective Cohort Study
Speaker: Xia Gan, MBBS - Hunan Cancer Hospital, Changsha -
04:45pm - 06:00pm PT
Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer
Speaker: Kara Ruicci, MD, PhD - University of Toronto, Toronto -
04:45pm - 06:00pm PT
OIP5 Mediates Radiotherapy Resistance in Lung Adenocarcinoma through POLD1-Dependent DNA Damage Repair
Speaker: Siwei Zeng, - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Optimizing Chemoradiotherapy for Small Cell Lung Cancer in the Immunotherapy Era
Speaker: Travis Lambert, MD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx -
04:45pm - 06:00pm PT
Optimizing Fractionation Strategies for Early-Stage NSCLC: Real-World Toxicity and Outcomes from a Statewide Consortium
Speaker: Luke Higgins, MD - University of Michigan, Ann Arbor -
04:45pm - 06:00pm PT
Outcomes and Toxicity of 60 Gy in 8 Fractions Stereotactic Body Radiotherapy to Peripheral Tumors Adjacent to the Chest Wall: A Single Institution Experience
Speaker: Tala Mobayed, MD - American University of Beirut Medical Center, Beirut -
04:45pm - 06:00pm PT
Outcomes and Treatment Patterns in Pediatric Head and Neck Rhabdomyosarcoma: A Retrospective Study of 105 Patients
Speaker: Mohammed Qamber, MD - Bahrain Oncology Center, Muharraq -
04:45pm - 06:00pm PT
Outcomes Following Proton Radiation for Pediatric Meningiomas
Speaker: Elizabeth Thompson, MD, BS - University of Florida, Gainesville -
04:45pm - 06:00pm PT
Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry
Speaker: Elaine Cha, MD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institution Population-Based Study
Speaker: Jose Miguel Callueng, MD - BC Cancer Agency - Kelowna, Muntinlupa City -
04:45pm - 06:00pm PT
Patient Reported Outcomes (PROs) after Radiation Therapy or Surgery followed by Radiation Therapy for Prostate Cancer
Speaker: Muhammad Shuja, MD - Mayo Clinic, Rochester -
04:45pm - 06:00pm PT
Patient-Reported Outcomes (PROs) in Prostate Cancer Patients Undergoing IMRT vs. IMRT with Brachytherapy
Speaker: Emily Hanus, BS - University of Kansas School of Medicine, Kansas City -
04:45pm - 06:00pm PT
Patterns of Failure and Toxicity in Patients with N2 vs. N3 Disease Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Speaker: Melanie Berger, MD - Hospital of the University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Patterns of Failure for Patients with Thymoma Treated with Post Operative Radiation Therapy
Speaker: Oded Icht, MD, MBA - Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto -
04:45pm - 06:00pm PT
Phenotyping Chronological Accumulation of Comorbidities for Prostate Cancer Patients: A Computational Approach
Speaker: Matthew Kim, BS - University of California, San Francisco, San Francisco -
04:45pm - 06:00pm PT
PIK3CD Affect Radiotherapy Resistance in LUAD Cells by Reprogramming Lipid Metabolism through PI3K/AKT Pathway
Speaker: Yingze Ma, MB, MBBS - Shandong Cancer Hospital and Institute, Jinan -
04:45pm - 06:00pm PT
Portrayal of Radiation Therapy in North American TV Shows
Speaker: Elsa Sutton, MD - Mayo Clinic Rochester, Rochester -
04:45pm - 06:00pm PT
Post Radiotherapy Lymphocyte Dynamics and Dose Constraints in Locally Advanced Thoracic Malignancies Undergoing Radical Radiotherapy
Speaker: Ben Man Fei Cheung, MD - Queen Mary Hospital, Hong Kong -
04:45pm - 06:00pm PT
Postmarketing Surveillance of Adverse Events after Immune Checkpoint Inhibitor Therapy and Radiotherapy
Speaker: Qian Zhang, MD, PhD, MS - McGaw Medical Center of Northwestern University, Chicago -
04:45pm - 06:00pm PT
Postoperative Radiotherapy in Surgically Resected Pathologic N2 Non-Small Cell Lung Cancer Post-Chemotherapy: A Multicenter Study
Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester -
04:45pm - 06:00pm PT
Practice Variations and Outcomes of Definitive Radiation for Non-Metastatic NSCLC following Induction Chemoimmunotherapy
Speaker: Troy Kleber, MD, MS - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Predicting Decreased Quality of Life in Cancer Survivors Undergoing Radiotherapy Using a Random Forest Model
Speaker: Meimei Shang, - Shandong Cancer Hospital and Institute, Shandong First University, Jinan -
04:45pm - 06:00pm PT
Prediction of Esophagitis following Intensity-Modulated Radiotherapy for Lung Cancer Using Statistical and Machine Learning Methods
Speaker: Nathaniel Miller, MD - Virginia Commonwealth University, Richmond -
04:45pm - 06:00pm PT
Prediction of Oligometastatic Disease from Breast Cancer Using Next Generation Sequencing Genomics
Speaker: Patrick Young, DO - Atrium Health Wake Forest Baptist, Winston-Salem -
04:45pm - 06:00pm PT
Predictive Risk Factors for Radiation Retinopathy in Eye Brachytherapy
Speaker: Zhibin Huang, PhD - Vitruvian Health, Murfreesboro -
04:45pm - 06:00pm PT
Preparation of mRNA-LNP Vaccine Based on HER2 Target and Its Antitumor Effect in Combination with Radiotherapy in Lung Cancer
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
04:45pm - 06:00pm PT
Primary Lesion-Directed Stereotactic Body Radiotherapy for Advanced Non-Small Cell Lung Cancer Treated with First-Line Systemic Therapy
Speaker: Dan Tao, MD - Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Prognostic Value and Immunological Correlation of Spleen Volume Change in Extensive-Stage Small-Cell Lung Cancer Treated with Chemo-Immunotherapy
Speaker: Xiuli Liu, MS - Department of Radiation Oncology, Shandong Cancer Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China, Jinan -
04:45pm - 06:00pm PT
Promise of LET-Optimized Intensity Modulated and Arc Proton Therapy for Pediatric Rhabdomyosarcoma: A Multi-Patient Comparative Dosimetry Study
Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville -
04:45pm - 06:00pm PT
Prophylactic Cranial Irradiation in Resected Early Stage Small Cell Lung Cancer: An Updated Systematic Review and Meta-Analysis
Speaker: Ze Yuan, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing -
04:45pm - 06:00pm PT
Prospective, Longitudinal Assessment of Financial Toxicity and Emotional Well-Being for Women with Gynecologic Cancers Receiving Radiotherapy
Speaker: Michayla Brown, MS - University of Alabama at Birmingham, Birmingham -
04:45pm - 06:00pm PT
Prospective Patient-Reported Outcomes (PRO) Regarding Skin Toxicity from Hypo-Fractionated Regional Nodal Irradiation (RNI) following Mastectomy and Lumpectomy
Speaker: Sunitha Varghese, MD, MBBS - The University of Kansas Health System, Kansas city -
04:45pm - 06:00pm PT
Prospective Validation of a Pretreatment 18F FDG PET CT plus Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Consolidation Immunotherapy
Speaker: Joseph Deasy, PhD - Memorial Sloan Kettering Cancer Center, New York -
04:45pm - 06:00pm PT
Proton Therapy for Hemithoracic Pleural Irradiation: A Step Toward Safer Radiation Treatment
Speaker: Drishti Panse, MD, BS - Icahn School of Medicine at Mount Sinai, New York -
04:45pm - 06:00pm PT
Proton Therapy for Pediatric Patients with Localized Unresectable Osteosarcoma
Speaker: Daniel Indelicato, MD, FASTRO - University of Florida Department of Radiation Oncology, Jacksonville -
04:45pm - 06:00pm PT
Proton Therapy in Pediatric Craniopharyngioma: Comparison between Adjuvant and Salvage Radiotherapy Efficacy and Toxicity
Speaker: Ory Haisraely, MD, MPH - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Quality-of-Life Metrics Correlate with Dual-Energy and 4D CT Derived Perfusion and Ventilation in Lung Cancer Patients 6 Months Post Radiation Therapy
Speaker: Maksym Sharma, PhD - University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Quantifying Radiation-Induced Pulmonary Fibrosis: A Novel CT-Based Approach to Measuring Lung Scarring after SBRT
Speaker: Asif Harsolia, MD - Memorial Radiation Oncology Medical Group, Fountain Valley -
04:45pm - 06:00pm PT
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
Speaker: David Kozono, MD, PhD - Dana-Farber Brigham Cancer Center, Boston -
04:45pm - 06:00pm PT
Radiomics Analysis in SBRT for Pulmonary Oligometastases: The Potential of Peritumoral Features in Predicting Treatment Response
Speaker: Yao Lu, MS - The First affiliated Hospital Zhejiang University School of Medicine, Hangzhou -
04:45pm - 06:00pm PT
Radiosurgery for Pediatric Central Nervous System Lesions - Initial Report and Insights from a Multicenter Registry
Speaker: Felix Ehret, MD - Massachusetts General Hospital, Boston -
04:45pm - 06:00pm PT
Randomization in Oligoprogressive Disease: Can We Still Run Trials, or Have We Lost Equipoise?
Speaker: Houda Bahig, MD, PhD - Centre Hospitalier de l'Universite de Montreal, Montreal -
04:45pm - 06:00pm PT
Rates of Fertility/Hormonal Preservation among Locally Advanced Cervical Cancer Patients Treated with Definitive Chemoradiation and Brachytherapy
Speaker: Stella Lymberis, MD - New York University Langone Medical Center, New York -
04:45pm - 06:00pm PT
Real World Radiographic Response Rates and Pre-Operative Attrition in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Neoadjuvant Chemoimmunotherapy
Speaker: Cole Friedes, MD - University of Pennsylvania, Philadelphia -
04:45pm - 06:00pm PT
Real-World Data of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer Patients
Speaker: Hao-Shen Cheng, MD - Taichung Veterans General Hospital, Taichung -
04:45pm - 06:00pm PT
Real-World Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SF-SABR) for Oligo-Persistent, Progressive, or Recurrent Primary and Metastatic Lung Tumors
Speaker: Wei-chieh Huang, MD - National Taiwan University Hospital, Taipei -
04:45pm - 06:00pm PT
Real-World Study on the Efficacy, Safety, and Prognostic Analysis of Chemotherapy Combined with Immunotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
04:45pm - 06:00pm PT
Refining SBRT for Ultra-Central NSCLC: Non-Uniform PTV and Strict OAR Constraints for Optimal Control and Minimal Toxicity
Speaker: Yaping Xu, PhD - Shanghai Pulmonary Hospital, Shanghai -
04:45pm - 06:00pm PT
Reirradiation for Pediatric Central Nervous System Tumors: Validation of an LQ Model-Based Approach for Critical Structure Dose Constraints and Clinical Outcomes
Speaker: Natalia Martynova, MD - Dr. Berezin Medical Institute, Saint-Petersburg -
04:45pm - 06:00pm PT
Reirradiation or Repeat Organ Irradiation for Non-Small Cell Lung Cancer: Oncological Outcomes and Toxicities
Speaker: Jonas Willmann, MD - University Hospital Zurich, Kilchberg -
04:45pm - 06:00pm PT
Representativeness and Generalizability of NCI-Funded Multi-Modality Randomized Clinical Trials (RCTs): A Case Study of Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Based on RTOG-0617 and the National Cancer Database (NCDB)
Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore -
04:45pm - 06:00pm PT
Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation
Speaker: Mary-Kate Lawlor, MD - Yale New Haven Health, New Haven -
04:45pm - 06:00pm PT
Risk of Cardiac Toxicity Influences Treatment Decisions in Lung Cancer: A National Survey
Speaker: Erik Blomain, MD, PhD - Thomas Jefferson University, Philadelphia -
04:45pm - 06:00pm PT
Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Bone Metastases: A Multicenter Retrospective Analysis
Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Safety and Activity of KRAS G12C Inhibitors Combined with Thoracic Radiation Therapy
Speaker: Helen Zhang, MD - Memorial Sloan Kettering Cancer Center, New York -
04:45pm - 06:00pm PT
Safety and Efficacy of Lung Stereotactic Body Radiation Therapy for Surgical Staple Line Recurrences
Speaker: Katie Scharf, MD - Rush University Medical Center, Chicago -
04:45pm - 06:00pm PT
Safety and Efficacy of Photon Re-Irradiation with Whole Brain Radiotherapy or Craniospinal Irradiation for Recurrent Pediatric Central Nervous System Malignancies
Speaker: Palak Patel, MD - Massachusetts General Brigham, Boston -
04:45pm - 06:00pm PT
Salvage Proton Therapy after Primary Cryosurgery or HIFU for Prostate Cancer
Speaker: Daniel Lichlyter, BS - University of Florida College of Medicine, Department of Radiation Oncology, Gainesville -
04:45pm - 06:00pm PT
Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy
Speaker: Min Li, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Secondary Imaging Analysis of a Clinical Trial Combining SABR and PEF Ablation for Central Lung Tumors
Speaker: Nicholas Peterson, MD - University of California, Irvine, Orange -
04:45pm - 06:00pm PT
Sexual Toxicity after Chemoradiation for Anal Cancer among Men who have Sex with Men
Speaker: Beck Gold, BS - George Washington University School of Medicine, Washington -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Single-Cell Atlas and Mechanistic Study of Lung Adenocarcinoma with Pulmonary Sarcomatoid Carcinoma
Speaker: Yuequn Ma, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Single-Fraction Lung SBRT for Primary and Metastatic Lung Tumors: Ten-Year Experience
Speaker: Luis Larrea, MD, PhD - Hospital Vithas Valencia Consuelo, Valencia -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Speaker: Cesar Marquez, MD, PhD - MD Anderson Cancer Center, Houston -
04:45pm - 06:00pm PT
Sociodemographic Factors Associated with Proton Therapy Accessibility in NRG Oncology Trials of Locally Advanced NSCLC
Speaker: Bryan Johnson, MD, MBA - Mayo Clinic Florida, Jacksonville -
04:45pm - 06:00pm PT
Sparing Secondary Lymphoid Organs Significantly Reduces Immune Suppression and Improves OS during Lung SBRT: Secondary Analysis of a Randomized, Phase 2 Trial
Speaker: Verny Rodriguez, MD - University of Kentucky, Lexington -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Stereotactic Radiosurgery for Recurrent Primary and Metastatic CNS Malignancies in the Pediatric Population
Speaker: Michael Gribble, MD - UCSF Radiation Oncology, San Francisco -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Study on the Mechanism of ATF3 in Regulating Radiation-Induced Lung Injury
Speaker: Yang Liu, RT - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan -
04:45pm - 06:00pm PT
Survival Disparities in Lung Cancer Based on Tumor Staging and Demographics in a Third World Country Radiation Therapy Cohort
Speaker: Daniel Przybysz, MD - RadioSerra Radiation Therapy, Rio de Janeiro -
04:45pm - 06:00pm PT
Targeting ADAM17 N-glycosylation Enhances Radiosensitivity in Non-Small Cell Lung Cancer via the NOTCH-ABCC1-ROS/cGAMP axis
Speaker: Ran Zhang, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
04:45pm - 06:00pm PT
Targeting Educational Needs and Patient Reported Outcomes in Spanish-Speaking Latino/a Radiation Oncology Patients
Speaker: Oscar Padilla, MD - Mount Sinai Hospital, New York -
04:45pm - 06:00pm PT
Targeting Protein Kinase CK2 to Reprogram Phospholipid Metabolism and Enhance the Efficacy of Radioimmunotherapy in Lung Cancer
Speaker: Rui Meng, PhD - Department of Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
04:45pm - 06:00pm PT
The Changing Dogma in Oligometastatic Renal Cell Carcinoma - SBRT
Speaker: Papaiah Susheela Sridhar, MD, DNB - Apollo Cancer centre,Bangalore, Bangalore -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
The Impact of Effective Dose to Immune Cells and Platelet-to-Lymphocyte Ratio on Lymphopenia and Prognosis in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Haoting Yang, MD - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
The Results of Re-Irradiation in Pediatric Recurrent Central Nervous System Tumors
Speaker: Ayca Iribas, MD - Istanbul University, Istanbul -
04:45pm - 06:00pm PT
The Role of Radiotherapy in Unresectable Primary Pulmonary Sarcoma: A Multicenter Study
Speaker: Ailing Liu, MD - Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer with Liver Metastases: A Multicenter Retrospective Evaluation of Survival Outcomes
Speaker: Xinyu Fan, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan -
04:45pm - 06:00pm PT
Too Full to Fail? Impact of Excessive Bladder Filling on Patient Experience in Prostate Cancer Radiotherapy
Speaker: Luke Peng, MD, MS - Brigham and Women's/Dana Farber Cancer Institute, Boston -
04:45pm - 06:00pm PT
Topical Honeysuckle Flower Gel for Radiation Dermatitis: A Novel Approach to Prevention and Management
Speaker: Chin-Nan Chu, MD, PhD - Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, R.O.C., Taichung -
04:45pm - 06:00pm PT
Toxicities of Brain and Spinal Cord Photon and Proton Radiation in Pediatric Brain Tumors Assessed by Real-World Data (RWD)
Speaker: Brandon Craig, MD, PhD - University of Calgary, Calgary -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Toxicity Profile for Connective Tissue Disease Patients Treated with Lung Stereotactic Body Radiation Therapy (SBRT)
Speaker: Adannia Ufondu, MD, BA - Cleveland Clinic, Cleveland -
04:45pm - 06:00pm PT
-
04:45pm - 06:00pm PT
Treatment Approach in Childhood Ewing Sarcoma - TROD Hematology Oncology Pediatric Oncology Total Body Irradiation Working Group Survey Study
Speaker: Candan Demiroz, MD, RT - Bursa Uludag University Faculty of Medicine, Bursa -
04:45pm - 06:00pm PT
Treatment Interruptions in NSCLC Radiotherapy: Impact on Outcomes in a Statewide Quality Collaborative
Speaker: Ameer Elaimy, MD, PhD, BS - University of Michigan Health System, Ann Arbor -
04:45pm - 06:00pm PT
Treatment Outcomes of High-Dose Hypofractionated Palliative Radiotherapy (40 Gy in 10 daily fractions) for Non-Small Cell Lung Cancer
Speaker: James Chow, MBChB - Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon -
04:45pm - 06:00pm PT
Treatment Strategy for Potentially Resectable Stage III-N2 Driver Gene-Negative NSCLC in the Immunotherapy Era
Speaker: Jiarui Zhao, MBBS - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan -
04:45pm - 06:00pm PT
Understanding Patient Priorities for Religious and Spiritual Needs during Radiotherapy for Gynecologic Malignancies
Speaker: Lauren Jacobs, MD - Mount Sinai Hospital, New York -
04:45pm - 06:00pm PT
Variation in Treatment Time and On-Board Imaging for Lung Tumors by Motion Management Technique: A Secondary Analysis of the iSABR Trial
Speaker: John Worth, BS - Stanford University, Palo Alto -
04:45pm - 06:00pm PT
Vertebral-Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients: Spinal Growth and Acute Toxicity Outcomes
Speaker: Chuyu Xia, MD - Peking University First Hospital, Beijing -
04:45pm - 06:00pm PT
Voxel-Based Analysis of Cardiac Radiosensitivity: Impact of Consolidation Immunotherapy after Chemoradiotherapy
Speaker: Hong In Yoon, MD, PhD - Yonsei University College of Medicine, Seoul -
04:45pm - 06:00pm PT
ZDHHC15 Mediated <em>S</em>-Palmitoylation of ENO1 Reprograms Glycometabolism to Confer Non-Small Cell Lung Cancer Radioresistance through Upregulating Ku70 and Ku80
Speaker: Zhiyuan Zhou, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan